CAY10746 is a selective Rho kinase (ROCK) inhibitor, targeting ROCK I and ROCK II with IC50 values of 0.014 µM and 0.003 µM, respectively. CAY10746 can be employed in the study of diabetic retinopathy.
Molecular Weight:
457.48
Purity:
99.04%
CAS Number:
[2247240-76-0]
Formula:
C26H23N3O5
Target:
ROCK
T36196
* VAT and and shipping costs not included. Errors and price changes excepted